Atezolizumab Plus Bevacizumab: A New Standard for Some NSCLC? Atezolizumab Plus Bevacizumab: A New Standard for Some NSCLC?

Encouraging findings with the combination suggest that it could offer a new standard treatment for patients with highly mutated non –small cell lung cancer.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news